MMRGlobal Announces U.S. Patent for Cancer Fighting Anti-CD20 Monoclonal Antibody

MMRGlobal Announces U.S. Patent for Cancer Fighting Anti-CD20 Monoclonal Antibody

LOS ANGELES, CA — (Marketwired) — 04/15/13 — (OTCQB: MMRF) ("MMR") today announced that the United States Patent and Trademark Office has issued a Notice of Allowance for the Company-s anti-CD20 monoclonal antibody assets, U.S. Serial No. 11/855,943, under the title, "Antibodies and Methods for Making and Using Them." This is the first U.S. patent to be granted for the Company-s anti-CD20 monoclonal antibodies, which have particular utility in fighting cancers. The anti-

Vitesse Schedules Earnings Call on May 7, 2013

Vitesse Schedules Earnings Call on May 7, 2013

CAMARILLO, CA — (Marketwired) — 04/15/13 — (NASDAQ: VTSS), a leading provider of advanced IC solutions for Carrier and Enterprise networks, will conduct a conference call on Tuesday, May 7, 2013, at 1:30 p.m. Pacific Time/4:30 p.m. Eastern Time to report financial results for the second quarter of fiscal year 2013.To listen to the conference call via telephone, dial 888.455.2263 (U.S. toll-free) or 719.457.2645 (International) and provide the passcode 9481541. Participants should dial in at